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Abstract
Objectives: Our aim was to analyze the clinical, pathological, and outcome characteristics of oral squamous cell 
carcinomas (OSCC) from a population of the north of Portugal.
Material and Methods: We conducted a descriptive study of 128 OSCC diagnosed between the years of 2000 and 
2010 in the Centro Hospitalar do Porto. Through of the review of the clinical records we studied several clinical, 
pathological, and outcome variables. The overall survival (OS) and disease-free survival (DFS) were analyzed by 
Kaplan-Meier method and log-rank test. Cox regression method was used for multivariate analysis.
Results: Of 128 patients with OSCC, 83 (64.8%) were male and 45 (35.2%) were female, (mean age of 62.13±15.57 
years). The most affected location was the tongue (n=52; 40.6%). The most common cause of reference was a non-
healing ulcer (n=35; 28.9%) followed by oral pain (n=27; 22.3%). Sixty (60.6%) patients were tobacco consumers 
and 55 (57.3%) alcohol consumers. The cumulative 3-years OS rate was 58.6% and DFS was 55.4%. In multivari-
able analysis for OS, we found an adverse independent prognostic value for advanced tumour size (p<0.001) and 
for the presence of perineural permeation (p=0.012). For DFS, advanced stage tumours presented adverse inde-
pendent prognostic value (p<0.001).
Conclusions: OSCC occurred most frequently in males, in older patients, and in patients with tobacco and/or alco-
hol habits. TNM and tumour stage additionally to the perineural permeation were the most important prognostic 
factors for the survival of these patients, contributing to identify high-risk subgroups and to guide therapy.
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Introduction
Oral cancer is a major public health problem worldwide. 
Oral and pharyngeal grouped together are the sixth most 
common cancers in the world (1). An estimated 263,900 
new cases and 128,000 deaths from lip and oral cavity 
cancer occurred in the year of 2008 worldwide (2). In 
Portugal, a total of 1200 cases of lip, oral and orophar-
ynx cancers were reported in 2007, 949 (78.61%) in 
males and 251 (21.4%) in females. Moreover, in the last 
decade there has been an increasing trend for oral can-
cer in Portuguese population in both sexes and espe-
cially in the female group (3). 
Almost 90% of oral cancers are squamous cell carcino-
mas (3). Smoking, alcohol use, and HPV infections are 
the major risk factors, with an attributable risk of oral 
cancer due to both tobacco and alcohol of 80% (4).
Despite recent advances in the detection and treatment 
of cancer, visual accessibility of the oral mucosa and the 
scientific knowledge on cancer risk factors, oral cancer 
carried a low survival rate (near 50%) in the last few 
decades (1). 
Treatment consists mainly in surgery, radiotherapy and/
or chemotherapy (5). However these treatment modali-
ties are often associated with collateral effects that di-
minish considerably the quality of life of the patients 
(6). Therefore is important to identify and stratify pa-
tients with greater precision to the most appropriate 
choice of a treatment plan, avoiding excessive treatment 
in patients with low risk of recurrence and excessively 
conservative treatments in patients in whom the risk of 
recurrence is high. 
The purpose of this study is to examine the clinical and 
pathological characteristics of oral squamous cell carci-
nomas (OSCC) and analyze their influence in the out-
come of these patients.
Material and Methods
-Patients population
This was a retrospective study of 128 consecutive pa-
tients diagnosed and treated for primary OSCC at the 
Centro Hospitalar do Porto – Hospital de Santo António, 
Porto, Portugal, between 2000 and 2010. The study was 
approved and performed according to the institutional 
review board of the hospital. We include all consecutive 
primary OSCC located in the lip mucosa or oral cavity 
(C00.3-C00.5, C01-06). Patients were excluded when 
lacking relevant clinical and follow-up information or 
without histological confirmation of their diagnosis. 
From patient’s records we obtained patient’s age, gen-
der, tumour location, first clinical manifestation of the 
disease, clinical tumour presentation, history of poten-
tially malignant disorders, tobacco and alcohol habits, 
tumour stage, primary treatment, tumour grade, surgi-
cal margin status, vascular, lymphatic and perineural 
invasion, and follow-up information.
The tobacco and alcohol habits were categorized into 
the groups: consumers, non consumers and ex-consum-
ers. Patients who smoked cigarettes (or equivalents) at 
the rate of 20 or more per day were considered heavy 
smokers (7). Those who drank alcohol at 30.0 g/day or 
more (for men) or 15.0 g/day or more (for women) were 
considered as heavy drinkers. 
Tumour stage was reclassified according to the 7th edi-
tion of the classification of malignant tumours of Amer-
ican Joint Committee on Cancer (8).  
Treatment options were registered and grouped for sta-
tistical analysis into the categories: 1 – surgery alone; 2 
– surgery and adjunctive radiotherapy (external-beam ra-
diotherapy, 55-66Gy); 3 – chemotherapy (5-fluorouracil 
and cisplatin) followed by surgery; 4 - chemotherapy fol-
lowed by surgery and adjunctive radiotherapy; 5 – other 
treatments including radiotherapy alone, chemotherapy 
alone or chemoradiotherapy; and 6 – support treatment. 
Hematoxylin-eosin-stained slides were available for all 
tumours to confirm the initial diagnosis. Tumour grade 
was reclassified into well differentiated (G1), moder-
ately differentiated (G2), and poorly differentiated (G3) 
OSCC. Inspection for possible presence of vascular (ve-
nous), lymphatic and perineural invasion reported as 
present or absent, was performed on each sample. Sur-
gical margin were classified according Sutton et al. (9).
-Statistical analysis
The descriptive results were reported as absolute and 
relative frequencies. Associations between categorical 
variables were analysed using Chi-square test. Overall 
survival (OS) was defined as the time interval (months) 
between primary treatment and death by oral cancer or 
last follow-up. Disease-free survival (DFS) was defined 
as the time interval (months) between primary treat-
ment and the first recurrence (whether local, regional 
or distant). The Kaplan-Meier method was used to plot 
survival curves and their prognostic effect was tested 
using the log-rank test. Variables with significant ef-
fects in the univariate analyses were entered into Cox 
proportional hazards model to investigate the independ-
ent effects of these variables.
Differences were considered statistically significant at 
p<0.05.  Statistical analyses were carried out using IBM 
SPSS Statistics version 21.0 software (IBM Corpora-
tion, NY, US). 
Results
-Clinical and pathological findings
The study group included 128 patients, 83 men (64.8%) 
and 45 women (35.2%), with a ratio male:female of 1.8:1, 
whose ages ranged from 21 to 96 years, with a mean age 
of 62.13 ±15.57 years. There were 17 (13.3%) cases be-
low the 45 years of age. Men were younger than women. 
Fifty men (60.2%) were under 62 years and 32 (71.1%) 
women had more than 62 years old (p=0.001).
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The most common clinical manifestation that brought 
the patient to the hospital was a non-healing ulcer in 
35 cases (31.8%) followed by oral pain (n=27; 24.5%), 
odynophagia (n=12; 10.9%), mass or nodule (n=11; 10%), 
persistent white or red patch (n=7; 6.4%), dysphagia (n=6; 
5.5%), cervical mass (n=5; 4.5%), prosthesis that fails to 
fit (n=3; 3.6%), oral haemorrhage (n=2; 1.8%), trismus 
(n=1; 0.9%%), and foreign body sensation in one patient 
(0.9%). This information was unknown in 18 cases.
The most frequently affected location was the tongue 
(n=52; 40.6%) followed by the floor of the mouth (n=19; 
14.8%), gingiva (n=15; 11.7%), hard palate (n=10; 7.8%), 
retromolar region (n=13; 10.2%), labial mucosa (n=11; 
8.6%), and buccal mucosa (n=8; 6.3%). 
In the cases with tobacco information (n=99) we found the 
report of tobacco consumption in 60 (60.6%) patients, of 
which 58 (58.6%) were heavy smokers. Seven (7.1%) pa-
tients were tobacco ex-consumers and 32 (32.3%) were 
non consumers. Alcohol consumption was registered in 55 
(57.3%) patients of whom 43 (44.8%) were heavy drinkers. 
Forty (41.7%) patients were alcohol non consumers and one 
(1%) patient was ex-consumer. In 32 cases alcohol infor-
mation was not available. Forty-two (43.8%) patients had 
simultaneous tobacco and alcohol consumption of which 
36 (37.5%) were both heavy smokers and heavy drinkers.
The relation between tobacco and alcohol habits with 
age, gender and tumour location is shown in table 1. 
We found a higher prevalence of smokers in males 
(p<0.001), and in the youngest age group (p<0.001). 
Moreover, males showed predominant alcohol misuse 
habits comparing to females (p<0.001). More than a 
half of the patients with tumours located on the floor of 
the mouth, retromolar trigone, and tongue were tobacco 
consumers (Table 1).
On the first intra-oral clinical examination, the tumour 
had an ulcer presentation in 55 cases (46.6%), an exo-
phytic (verruciform) appearance in 19 (16.1%) cases, an 
ulcer-exophytic appearance in 37 (31.4%) cases and a 
patch (white or red) presentation in 7 (5.9%) cases in the 
118 cases with this information. History of leukoplakia 
was recorded in 17 (13.3%) cases, erythroplakia in 3 
(2.3%) and actinic cheilitis (on lip) in 3 (2.3%) cases.
Tumours were T1 in 34 cases (26.6%), T2 in 47 cases 
(36.7%), T3 in 10 cases (7.8%), T4a in 31 cases (24.2%), 
and T4b in 6 cases (4.7%). Fifty patients (39%) had tu-
mour nodal involvement. N1 status was found in 19 
(14.8%) patients, N2 in 26 patients (20.3%), and N3 in 5 
patients (3.9%). One subject (0.8%) had a distant metas-
tasis (lung) at time of diagnosis. 
In the view of this, 26 patients (20.3%) presented stage-I 
tumours, 32 patients (25%) had stage-II tumours, 20 pa-
tients (15.6%) presented stage-III tumours, 40 patients 
(31.3%) had stage-IVA tumours, 9 (7%) stage-IVB tu-
mours, and one (0.8%) had a stage-IVC tumour. 
Fifty-eight patients (45.3%) were treated with surgery 
alone, 37 (28.9%) with surgery and adjunctive radio-
therapy, 3 (2.3%) with chemotherapy followed by sur-
gery, 7 (5.5%) with chemotherapy followed by surgery 
and adjunctive radiotherapy, and 10 (7.8%) with other 
treatments including radiotherapy alone, chemotherapy 
alone or chemoradiotherapy. Thirteen patients (10.2%) 
received only support treatment. 
Tumours were graded as well-differentiated in 74 (57.8%) 
cases, moderately differentiated in 45 (35.2%), and poorly 
differentiated in 9 (7%) cases. Of the 105 patients submit-
ted to surgery, there were 60 cases with report of surgical 
margin status. Eleven (18.3%) patients had tumour cells in 
the surgical margins, 33 (55%) were free of tumour cells, 
Table 1. Associations between tobacco/alcohol habits with age, gender and tumour location.
Tobacco Alcohol
Consumer Heavy smoker Consumer Heavy drinker
No
(n; %) 
Yes
(n; %) 
No
(n; %) 
Yes
(n; %) 
No
(n; %) 
Yes
(n; %) 
No
(n; %) 
Yes
(n; %) 
Age
<49 years 
49-63 years 
64-74 years 
>75 years 
7 (23.3) 
8 (26.7) 
7 (36.8) 
17 (85) 
23 (76.7) 
22 (73.3) 
12 (63.2) 
3 (15) 
7 (23.3) 
10 (33.3) 
7 (36.8) 
17 85) 
23 (76.7) 
20 (66.7) 
12 (63.2) 
3 (15) 
11 (36.7) 
9 (34.6) 
9 (45) 
12 (60) 
19 (63.3) 
17 (65.4) 
11 (55) 
8 (40) 
14 (46.5) 
13 (50) 
11 (55) 
15 (75) 
16 (53.3) 
13 (50) 
9 (45) 
5 (25) 
p-value <0.001 <0.001 0.304 0.227 
Gender 
Female 
Male 
19 (76) 
20 (27) 
6 (24) 
54 (73) 
20 (80) 
21 (28.4) 
5 (20) 
53 (71.6) 
19 (76) 
22 (31) 
6 (24) 
49 (69) 
21 (84) 
32 (45.1) 
4 (16) 
39 (54.9) 
p-value <0.001 <0.001 <0.001 0.01 
Location
Labial mucosa 
Floor of the mouth 
Tongue
Buccal mucosa 
Retromolar trigone 
Hard palate 
Gingiva
3 (75) 
0
19 (46.3) 
4 (80) 
3 (25) 
4 (50) 
6 (60) 
1 (25) 
19 (100) 
22 (53.7) 
1 (2) 
9 (75) 
4 (50) 
4 (40) 
3 (75) 
1 (5.3) 
20 (48.8) 
4 (80) 
3 (25) 
4 (50) 
6 (60) 
1 (25) 
18 (94.7) 
21 (51.2) 
1 (20) 
9 (75) 
4 (50) 
4 (40) 
3 (50) 
4 (23.5) 
23 (56.1) 
2 (50) 
2 (18.2) 
3 (33.3) 
4 (50) 
3 (50) 
13 (76.5) 
18 (43.9) 
2 (50) 
9 (81.8) 
6 (66.7) 
4 (50) 
3 (50) 
5 (29.4) 
29 (70.7) 
3 (75) 
4 (36.4) 
4 (44.4) 
5 (63.5) 
3 (50) 
12 (70.6) 
12 (29.3) 
1 (25) 
7 (63.6) 
5 (55.6) 
3 (37.5) 
p-value 0.001 0.04 0.175 0.076 
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and 16 (26.7%) were close to tumour cells. We found vas-
cular invasion in 11 (11.2%) cases, perineural permeation 
in 14 (14.3%) cases, and lymphatic invasion in 19 (19.4%) 
in the 98 cases wherethis analysis was available. 
-Clinical Outcome
At the end of our study, 68 patients (53.1%) were alive 
without oral cancer, 2 patients (1.6%) were alive with oral 
cancer, 56 (43.8%) had died as a result of the oral cancer 
and 2 patients (1.6%) had died as a result of other non-
cancer disease. The follow-up mean for all patients was 
33.2±28.8 months. The cumulative 3-years OS rate was 
58.6% and DFS was 55.4%. At 5-years OS and DFS rates 
corresponded to 50.5% and 49.5%, respectively (Fig. 1).
In univariable analysis, tumour location (p=0.034), 
T status (p<0.001) (Fig. 2), N status (p<0.001), clini-
cal stage (p<0.001), surgical margins (p=0.001), treat-
ment option (p<0.001), histological grade (p<0.001), 
vascular invasion (p=0.005), and perineural permea-
tion (p<0.001) (Fig. 2) were statistically correlated to 
OS. The same was observed with reference to DFS for 
T status (p=0.001), N status (p<0.001), clinical stage 
(p<0.001) (Fig. 3), treatment option (p=0.01), surgical 
margins (p=0.038), histological grade (p=0.041), and 
perineural permeation (p=0.007) (Table 2).
In multivariable analysis for OS, we found an adverse 
independent prognostic value for advanced tumour size 
(T) and for the presence of perineural permeation (Table 
3). For DFS, advanced clinical stage presented adverse 
independent prognostic value (Table 4).
Discussion
Few studies have characterised oral cancers in the Por-
tuguese population (10,11). With this in mind, we ana-
lysed the clinical and pathological features and the out-
come of a series of patients with OSCC from a central 
hospital in the north of Portugal.
We observed that oral cancer was twice more frequent 
in males than females (ratio 1.8:1) which is in accord-
ance with the predominant male frequency of this cancer 
reported in literature (12). However this ratio was lower 
than the reported by others (10,11,13,14). This could be 
attributed to the increasing trend of oral cancer in women 
in Portugal or simply be a result of sample constitution 
(3). The mean age (62 years) found in the present study 
is compatible with the majority of the published studies 
(10,12,15). There were 13.3% of the patients with less 
than 45 year-old, result that has been described with in-
creasing frequency in the literature (16-18).
Fig. 1. Kaplan-Meier plots to overall survival (A) and disease-free survival (B).  
Fig. 2. Kaplan-Meier plots to overall survival according T category of TNM classification (A) and perineural permeation (B).
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Variable N dead OS p-value N recurrence DFS p-value 
Gender 
      Female 
      Male 
45 
83 
17 
39 
62.9 
58.1 
0.439 37 
64 
17 
27 
56.7 
56.7 
0.609 
Age
     <49 years 
     49-63 years 
     64-74 years 
     >75 years 
32 
34 
28 
34 
17 
15 
11 
13 
58 
57 
61.8 
63 
0.814 
24 
27 
22 
28 
12 
14 
8
10 
49.5 
48 
59.9 
66.5 
0.721 
Tumour location 
      Labial mucosa 
      Floor of the mouth  
      Tongue 
      Buccal mucosa  
      Retromolar trigone  
      Hard palate 
      Gingiva
11 
19 
52 
8
13 
10 
15 
1
11 
18 
4
7
6
9
90 
52.1 
66.2 
62.5 
59.2 
50 
34.4 
0.034 
11 
14 
44 
6
10 
6
10 
2
10 
16 
3
5
3
5
80 
28.6 
66 
50 
56 
44.4 
41.7 
0.244 
Tobacco consumption*
      No 
      Yes 
39 
60 
19 
29 
56.2 
58 
0.860 31 
46 
15 
21 
51.6 
54.4 
0.411 
Heavy Smoking*
      No  
      Yes 
41 
58 
20 
28 
55.9 
58.3 0.811 
33 
44 
17 
19 
47.2 
57.7 
0.229 
Alcohol consumption*
      No 
      Yes 
41 
55 
19 
27 
54.8 
59.8 
0.963 33 
42 
16 
18 
48.7 
57.7 
0.417 
Heavy drinker*
      No
      Yes
53 
43 
24 
22 
59.5 
55.7 
0.690 43 
32 
20 
14 
50.4 
58.7 
0.567 
T status 
      T1 
      T2 
      T3 
      T4 (T4a+T4b)
34 
47 
10 
37 
4
13 
7
32 
90.5 
79 
30 
16.4 
<0.001 
34 
46 
6
15 
10 
19 
4
11 
67.5 
60.3 
33.3 
24 
0.001 
N status 
      0 
      1 
      2 
      3 
78 
19 
26 
5
22 
10 
21 
3
74.5 
55.3 
24.4 
40 
<0.001 
68 
15 
16 
2
21 
10 
12 
1
68.5 
45 
18.8 
50 
<0.011 
Stage 
      I 
      II 
      III 
      IV (IVA+IVB+IVC) 
26 
32 
20 
50 
2
6
8
40 
95.8 
83.5 
67.9 
23.6 
<0.001 
26 
31 
19 
25 
6
9
11 
18 
78.9 
74.6 
51.3 
23.5 
<0.001 
Treatment options 
      SG 
      SG+RT 
      CT+SG 
      CT+SG+RT 
      CT or RT or RCT 
      ST 
58 
37 
3
7
10 
13 
9
20 
2
4
8
13 
87.2 
55.2 
33.3 
57.1 
12.5 
0
<0.001 
55 
34 
2
5
5
0
15 
21 
1
3
4
-
70.6 
42.2 
50 
60 
20 
-
0.010 
Tumour grade 
      G1 
      G2+G2 
74 
54 
21 
35 
74.5 
41 
<0.001 62 
39 
22 
22 
66 
43 
0.041 
Margin status*
      Free of tumour 
      Close to the tumour 
      With tumour 
33 
16 
11 
10 
6
5
80 
66.7 
70.7 
0.782 
30 
16 
10 
9
10 
6
72.5 
35.7 
32 
0.063 
Vascular invasion*
      Absent  
      Present 
87 
11 
27 
7
74.2 
36.4 
0.005 81 
9
34 
5
57.8 
44.4 
0.304 
Perineural permeation*
      Absent  
      Present
84 
14 
24 
10 
76.6 
28.6 
<0.001 79 
11 
31 
8
60.4 
27.3 
0.007 
Lymphatic invasion*
      Absent  
      Present
79 
19 
25 
9
74.3 
51.5 
0.082 72 
18 
29 
10 
60.2 
44.4 
0.091 
Table 2. Kaplan-Meier estimates of probability of overall survival and disease-free survival at 3 years of follow-up 
(univariate analysis).
OS, overall survival; DFS, disease-free survival; SG, surgery; RT, radiotherapy; CT, chemotherapy; RCT, chemoradio-
therapy; ST, support treatment *information not available for every patient.
Tobacco and/or alcohol habits were present in more than 
a half of the patients and were predominant in males. 
This is an expected result in squamous cell carcinomas 
of the oral cavity, reflecting the importance of these 
habits as risk factors in oral cancer (4,10). Therefore, 
primary prevention measures must be strengthened to a 
decrease of such habits. 
In the last decades, an important role of HPV on the 
aetiology of oral cancer has been suggested (4). How-
ever, in many cases HPV detection in oral tumours 
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Fig. 3. Kaplan-Meier plots to disease-free survival according 
clinical tumour stage.
Variable p-value* HR* 95% CI*
T status
      T1
      T2
      T3
      T4 (T4a+T4b)
0.207
0.019
<0.001
1
2.125
5.654
12.938
0.659-7.850
1.332-33.991
4.102-40.805
Perineural permeation
      Absent 
      Present 0.012
1
2.784 1.251-6.194
Table 3. Variables with significant independent effect in the multivariate Cox regression analysis of the overall survival.
HR, hazard ratio; CI, confidence interval for HR.
*values adjusted for tumour location; T status;  N status; clinical stage; treatment option; tumour grade; vascular 
invasion: and perineural permeation.
Variable p-value* HR* 95% CI*
Stage
      I
      II
      III
      IV (IVA+IVB)
0.251
0.026
<0.001
1
1.898
3.464
7.529
0.635-5.673
1.158-10.360
2.707-20.937
Table 4. Variables with significant independent effect in the multivariate Cox regression analy-
sis of the disease-free survival.
HR, hazard ratio; CI, confidence interval for HR.
*values adjusted for T status; N status; clinical stage; treatment option; tumour grade; and 
perineural permeation.
specimens is not routinely done probably due to the 
high cost of HPV DNA identification techniques. Some 
authors proposed p16 immunohistochemical detection 
as a marker of HPV infection (19). We think that this 
could be a more cost-effective option as a routine first-
line marker of HPV in oral cancers specimens.  It is our 
objective, in the future, to analyse HPV status with p16 
immunostaining and with HPV in situ hybridization 
techniques in these tumours.
More than a half of the patients had an advanced tumour 
stage at presentation. This is in accordance with the re-
sults from other Portuguese studies (10) but contrast with 
some recent publications regarding oral cancer in Spain 
where most of patients had stage I or II tumours (13,20). 
One of the reasons for this may be related with the pos-
sible low awareness of the population for oral cancer (7).
The rates of OS and DFS at 60 months were 50.5% 
and 49.5%, respectively, which are in accordance with 
the described survival rate for oral cancer in the most 
parts of the world (1,12,21-23). However, recent US data 
showed a statistically significant improvement in overall 
survival among patients treated for OSCC from 54% in 
1987-1989 to 63% in the 2001-2007 timeframe (24). 
Age and gender did not influence the OS and DFS, simi-
lar to the observed in several studies (25-27). Tobacco 
and alcohol consumption also did not influence the out-
come of these patients, as observed by Vallecillo-Capi-
lla et al. (13).
Tumour staging, using TNM classification, is the most 
common and accepted prognostic system for patients 
with cancer (28). Several studies have demonstrated the 
independent prognostic value of TNM classification on 
oral cancer (13-15,29). We confirmed this in the present 
work. The T and N categories and the tumour stage 
showed a highly significant association with OS and DFS 
in the univariate analysis. In the multivariate ana-lysis T 
category had an independent prognostic value on the OS. 
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Patients with T4 tumours showed a hazard ratio value 13 
times higher than patients with T1 tumours. Tumour stage 
revealed an independent prognostic value in disease-free 
survival. Patients with stage IV tumours showed a hazard 
ratio value 8 times higher than patients with stage I tu-
mours. Moreover as we already saw in this study, most of 
the patients were diagnosed in advanced stages already. 
This reflects the need for early diagnosis of this pathol-
ogy at least in the north of Portugal. This is a concerning 
problem that needs to be strengthened in Portugal with 
several measures such as awareness and knowledge cam-
paigns on oral cancer, and oral cancer screenings.
The histologic grade showed, in the present work, that 
well differentiated tumours had a better outcome on uni-
variate analysis than less differentiated tumours. Howev-
er, this variable lost significance in multivariate analysis. 
Nevertheless, Kademani et al (27) reported the independ-
ent value of the degree of cellular differentiation as a pre-
dictor of the survival of patients with OSCC. 
The presence of perineural permeation was a strong in-
dicator of an adverse OS with an independent effect on 
multivariate analysis. The perineural spread is reported 
at a frequency between 6 and 30% in several head and 
neck carcinomas and regarded as an important progno-
sis factor (30).
In conclusion, this study indicates that OSCC occurred 
most frequently in males, in older patients, and in pa-
tients with tobacco and/or alcohol habits. Non-healing 
ulcers and oral pain were the most common reasons for 
the first clinical examination, very often in an advanced 
tumour stage. TNM and tumour stage classification and 
perineural permeation were the most important prognos-
tic factors for the survival of these patients, contributing 
to identify high-risk subgroups and to guide therapy.
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